These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2913154)

  • 1. Production of hybrid hybridomas based on HAT(s)-neomycin(r) double mutants.
    De Lau WB; Van Loon AE; Heije K; Valerio D; Bast BJ
    J Immunol Methods; 1989 Feb; 117(1):1-8. PubMed ID: 2913154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced formation of mouse hybridomas without hat treatment in a serum-free medium.
    Yabe N; Matsuya Y; Yamane I; Takada M
    In Vitro Cell Dev Biol; 1986 Jul; 22(7):363-8. PubMed ID: 3733634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid hybridomas producing bispecific antibodies to CEA and peroxidase isolated by a combination of HAT medium selection and fluorescence activated cell sorting.
    Jantscheff P; Winkler L; Karawajew L; Kaiser G; Böttger V; Micheel B
    J Immunol Methods; 1993 Jul; 163(1):91-7. PubMed ID: 8335963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of murine hybrid-hybridomas secreting bispecific monoclonal antibodies for use in urease-based immunoassays.
    Takahashi M; Fuller SA
    Clin Chem; 1988 Sep; 34(9):1693-6. PubMed ID: 2458200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of hybrids secreting bispecific antibodies recognising CEA and doxorubicin.
    Reddy VS; Ford CH
    Anticancer Res; 1993; 13(6A):2077-83. PubMed ID: 8297116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of functional human T-T hybridomas in selection medium lacking aminopterin and thymidine.
    Foung SK; Sasaki DT; Grumet FC; Engleman EG
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7484-8. PubMed ID: 6984190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-step method for establishing 8-azaguanine-resistant hybridomas suitable for the preparation of triomas.
    Kontsekova E; Novak M; Macikova I; Kontsek P
    J Immunol Methods; 1991 Dec; 145(1-2):247-50. PubMed ID: 1765658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of heteromyeloma fusion partners which promote the outgrowth of porcine hybridomas.
    Greenlee AR; Magnuson NS; Smith C; Butt BM; McKiernan AJ; Davis WC
    Vet Immunol Immunopathol; 1990 Nov; 26(3):267-83. PubMed ID: 2264287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A human hybrid hybridoma.
    Tiebout RF; van Boxtel-Oosterhof F; Stricker EA; Zeijlemaker WP
    J Immunol; 1987 Nov; 139(10):3402-5. PubMed ID: 3119707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple metabolic system for selection of hybrid hybridomas (tetradomas) producing bispecific monoclonal antibodies.
    Chervonsky AV; Faerman AI; Evdonina LV; Jazova AK; Kazarov AR; Gussev AI
    Mol Immunol; 1988 Sep; 25(9):913-5. PubMed ID: 2463483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 8-Azaguanine resistant African green monkey kidney cell mutants (Vero 153): isolation and characterization.
    Lee CL; Lee SH; Rozee KR; Chen SH
    In Vitro; 1983 May; 19(5):416-20. PubMed ID: 6190732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and characterization of a novel fusion partner cell line for the production of human macrophage hybridoma.
    Park JH; Cho EW; Lee YJ; Hahm KS; Kim KL
    Hybridoma; 1997 Dec; 16(6):551-6. PubMed ID: 9455709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the activity of an avian gene transferred into a mammalian cell by cell fusion.
    Klinger HP; Shin SI
    Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1398-402. PubMed ID: 4524645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The production of a bispecific anti-CEA, anti-hapten (4-amino-phthalate) hybrid-hybridoma.
    Lloyd F; Goldrosen M
    J Natl Med Assoc; 1991 Oct; 83(10):901-4. PubMed ID: 1800765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of hybridoma formation by addition of insulin to HAT medium (HIAT).
    Feit C; Bartal AH; Hirshaut Y
    Hybridoma; 1984; 3(4):377-80. PubMed ID: 6396198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of mammalian cell lines carrying suppressible mutations.
    López-Revilla R; Martínez HG; Santos-Díaz MS
    Mol Gen Genet; 1988 Jul; 213(1):105-11. PubMed ID: 3221837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-ray-induced mutants resistant to 8-azaguanine. II. Cell cycle dose response.
    Carver JH; Dewey WC; Hopwood LE
    Mutat Res; 1976 Mar; 34(3):465-79. PubMed ID: 1264111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The generation of stable human T-cell hybridomas which constitutively produce interleukin-2 and chemotactic factor.
    Foon KA; Rossio JL; Schroff RW; Wahl SM; Ruscetti FW; Abrams PG; Rager HC; Pickeral SF; Fidler IJ
    Hybridoma; 1985; 4(3):211-22. PubMed ID: 3930388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and testing of mouse--human heteromyelomas for human monoclonal antibody production.
    Teng NN; Lam KS; Calvo Riera F; Kaplan HS
    Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7308-12. PubMed ID: 6316357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A new approach to the design of hybrid hybridomas based on the use of an actinomycin D-resistant line of murine myeloma].
    Massino IuS; Kizim EA; Dmitriev AD
    Biull Eksp Biol Med; 1991 Nov; 112(11):511-4. PubMed ID: 1687361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.